Cue Biopharma, Inc.
NASDAQ:CUE
1.49 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 2.658 | 1.717 | 1.821 | 2.1 | 1.382 | 0.187 | 0.151 | 0.068 | 0.026 | 1 | 8.254 | 2.395 | 2.739 | 1.553 | 0.475 | 0.704 | 1.075 | 0.9 | 1.049 | 0.984 | 1.055 | 0.37 | 0.331 | 0.449 | 0.172 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.866 | 0.849 | 0.851 | 0.857 | 0.848 | 0.88 | 0.58 | 0.539 | 0.458 | 0.229 | 6.687 | 11.288 | 8.762 | 9.816 | 13.143 | 6.067 | 8.119 | 9.906 | 6.964 | 5.302 | 6.867 | 8.353 | 6.823 | 10.313 | 5.414 | 5.819 | 9.019 | 4.002 | 3.417 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 1.792 | 0.868 | 0.97 | 1.243 | 0.534 | -0.693 | -0.429 | -0.471 | -0.432 | 0.771 | 1.567 | -8.893 | -6.023 | -8.263 | -12.667 | -5.363 | -7.044 | -9.006 | -5.915 | -4.318 | -5.812 | -7.983 | -6.492 | -9.864 | -5.242 | -5.819 | -9.019 | -4.002 | -3.417 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.674 | 0.506 | 0.533 | 0.592 | 0.386 | -3.706 | -2.836 | -6.926 | -16.615 | 0.771 | 0.19 | -3.713 | -2.199 | -5.321 | -26.65 | -7.618 | -6.553 | -10.007 | -5.639 | -4.388 | -5.509 | -21.576 | -19.638 | -21.969 | -30.477 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 9.53 | 10.199 | 10.787 | 9.874 | 10.65 | 9.391 | 11.332 | 7.571 | 9.592 | 10.082 | 11.501 | 11.288 | 8.762 | 9.816 | 8.004 | 7.517 | 8.119 | 9.906 | 6.965 | 5.302 | 6.867 | 8.353 | 6.823 | 10.313 | 5.414 | 5.819 | 9.02 | 4.002 | 3.417 | 2.461 | 2.065 | 1.4 | 1.195 | 1.195 |
| General & Administrative Expenses
| 3.511 | 4.186 | 4.609 | 3.645 | 4.249 | 4.176 | 3.704 | 3.528 | 3.782 | 5.156 | 4.728 | 4.099 | 4.28 | 4.255 | 3.521 | 3.293 | 3.872 | 3.989 | 3.1 | 2.776 | 3.419 | 3.444 | 4.474 | 2.895 | 2.23 | 1.703 | 1.419 | 1.03 | 0.996 | 0.889 | 0.777 | 0.624 | 0.174 | 0.174 |
| Selling & Marketing Expenses
| -0.866 | -0.849 | -0.751 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.218 | 0.218 |
| SG&A
| 2.645 | 3.337 | 3.858 | 3.645 | 4.249 | 4.176 | 3.704 | 3.528 | 3.782 | 5.156 | 4.728 | 4.099 | 4.28 | 4.255 | 3.521 | 3.293 | 3.872 | 3.989 | 3.1 | 2.776 | 3.419 | 3.444 | 4.474 | 2.895 | 2.23 | 1.703 | 1.419 | 1.03 | 0.996 | 0.889 | 0.777 | 0.624 | 0.392 | 0.392 |
| Other Expenses
| -9.53 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.025 | 0.025 | 0 | 0 | 0 | -0.023 | -0.025 | -0.026 | -0.012 | 0.005 | 0.026 | 0.046 | 0.066 | 0.098 | 0.002 | -0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 12.175 | 13.536 | 14.645 | 13.519 | 14.899 | 13.567 | 15.036 | 11.099 | 13.374 | 15.238 | 16.148 | 15.412 | 13.042 | 14.071 | 11.45 | 10.835 | 12.017 | 13.895 | 10.065 | 8.078 | 10.286 | 11.797 | 11.297 | 13.208 | 7.644 | 7.522 | 10.439 | 5.032 | 4.413 | 3.35 | 2.842 | 2.024 | 1.396 | 1.396 |
| Operating Income
| -10.383 | -12.668 | -13.675 | -11.419 | -13.517 | -13.38 | -14.866 | -11.031 | -13.09 | -14.238 | -7.893 | -13.018 | -10.303 | -12.518 | -10.975 | -10.131 | -10.942 | -12.995 | -9.016 | -7.094 | -9.231 | -11.427 | -10.967 | -12.759 | -7.472 | -7.522 | -10.439 | -5.032 | -4.413 | -3.35 | -2.842 | -2.024 | -1.396 | -1.396 |
| Operating Income Ratio
| -3.906 | -7.378 | -7.51 | -5.438 | -9.781 | -71.551 | -98.301 | -162.221 | -503.462 | -14.238 | -0.956 | -5.435 | -3.762 | -8.061 | -23.089 | -14.391 | -10.179 | -14.439 | -8.595 | -7.209 | -8.75 | -30.884 | -33.172 | -28.416 | -43.442 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 0.212 | 0.321 | 0.241 | 0.414 | 0.332 | 0.271 | 0.273 | 0.076 | -0.118 | -0.017 | -0.001 | 0.026 | 0.024 | 0.013 | 0.078 | -0.023 | -0.025 | -0.026 | -0.012 | 0.005 | 0.026 | 0.046 | 0.066 | 0.098 | 0.002 | -0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax
| -10.171 | -12.347 | -13.434 | -11.005 | -13.185 | -13.109 | -14.592 | -10.955 | -13.208 | -14.255 | -7.89 | -12.992 | -10.279 | -12.505 | -10.897 | -10.031 | -10.833 | -12.818 | -8.918 | -6.99 | -9.109 | -11.267 | -10.796 | -12.559 | -7.3 | -7.523 | -10.439 | -5.032 | -4.413 | -3.35 | -2.842 | -2.024 | -1.396 | -1.396 |
| Income Before Tax Ratio
| -3.827 | -7.191 | -7.377 | -5.24 | -9.541 | -70.102 | -96.493 | -161.103 | -508 | -14.255 | -0.956 | -5.425 | -3.753 | -8.052 | -22.925 | -14.249 | -10.077 | -14.242 | -8.501 | -7.104 | -8.634 | -30.451 | -32.656 | -27.971 | -42.442 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0.806 | 0.807 | 0.7 | 0.564 | 0.099 | -0.138 | -0.076 | 0.118 | 0.017 | 0.495 | 0.002 | 0 | 0 | 0.206 | -0.123 | 0.618 | -0.203 | -0.001 | -0.099 | 0.413 | -0.114 | -825 | -0.102 | -0.17 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income
| -10.171 | -12.347 | -13.434 | -11.005 | -13.185 | -13.208 | -14.454 | -10.879 | -13.326 | -14.272 | -8.384 | -12.993 | -10.279 | -12.505 | -11.103 | -10.031 | -10.833 | -12.818 | -8.918 | -6.99 | -9.522 | -11.267 | -11.621 | -12.559 | -7.3 | -7.523 | -10.439 | -5.032 | -4.413 | -3.35 | -2.842 | -2.024 | -1.396 | -1.396 |
| Net Income Ratio
| -3.827 | -7.191 | -7.377 | -5.24 | -9.541 | -70.631 | -95.578 | -159.985 | -512.538 | -14.272 | -1.016 | -5.425 | -3.753 | -8.052 | -23.359 | -14.249 | -10.077 | -14.242 | -8.501 | -7.104 | -9.026 | -30.451 | -35.152 | -27.971 | -42.442 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.2 | -0.25 | -0.28 | -0.24 | -0.29 | -0.3 | -0.37 | -0.31 | -0.38 | -0.44 | -0.27 | -0.41 | -0.33 | -0.41 | -0.37 | -0.34 | -0.38 | -0.48 | -0.37 | -0.31 | -0.46 | -0.54 | -0.58 | -0.62 | -0.36 | -0.37 | -0.51 | -0.24 | -0.21 | -0.16 | -0.14 | -0.098 | -0.19 | -0.19 |
| EPS Diluted
| -0.2 | -0.25 | -0.28 | -0.24 | -0.29 | -0.3 | -0.37 | -0.31 | -0.38 | -0.44 | -0.27 | -0.41 | -0.33 | -0.41 | -0.37 | -0.34 | -0.38 | -0.48 | -0.37 | -0.31 | -0.46 | -0.54 | -0.56 | -0.62 | -0.36 | -0.37 | -0.51 | -0.24 | -0.21 | -0.16 | -0.14 | -0.098 | -0.19 | -0.19 |
| EBITDA
| -9.517 | -11.819 | -12.824 | -9.863 | -12.104 | -11.859 | -13.672 | -10.292 | -12.876 | -13.927 | -7.894 | -12.701 | -9.989 | -12.2 | -10.721 | -9.862 | -10.916 | -11.734 | -9.016 | -5.876 | -8.014 | -10.221 | -10.763 | -12.565 | -7.277 | -7.355 | -10.312 | -4.908 | -4.311 | -3.283 | -2.78 | -1.968 | -1.354 | -1.354 |
| EBITDA Ratio
| -3.581 | -6.884 | -7.042 | -4.697 | -8.758 | -63.417 | -90.408 | -151.353 | -495.231 | -13.927 | -0.956 | -5.303 | -3.647 | -7.856 | -22.555 | -14.009 | -10.154 | -13.038 | -8.595 | -5.972 | -7.596 | -27.624 | -32.554 | -27.984 | -42.308 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |